Literature DB >> 19412649

A potential role for inducible nitric oxide synthase in the cerebral response to acute hemodilution.

Anya T McLaren1, C David Mazer, Haibo Zhang, Elaine Liu, Lillian Mok, Gregory M T Hare.   

Abstract

PURPOSE: Acute anemia increases the cerebral expression of hypoxic molecules including neuronal nitric oxide synthase (nNOS) and hypoxia inducible factor-1alpha (HIF-1alpha). This study assessed the effects of acute hemodilution on inducible NOS (iNOS) and systemic inflammatory cytokines.
METHODS: Anesthetized rats (n = 5-7 per group) underwent 50% hemodilution with pentastarch, whole blood exchange or no fluid exchange. Cerebral cortical nNOS and iNOS protein levels were characterized using Western blot analysis and immunostaining (1 and 18 h). Plasma cytokine levels were assessed by enzyme-linked immunosorbent assay (1, 4, and 18 h). Data were analyzed by two-way analysis of variance to determine significance (P < 0.05, mean +/- SD).
RESULTS: No differences in mean arterial blood pressure or arterial blood gases were observed between groups after hemodilution. A comparable hemoglobin target (approximately 70 g . L(-1)) was achieved in all groups following hemodilution. Cerebral cortical iNOS protein levels were increased in anemic rats, relative to controls. The nNOS protein levels increased to a greater degree (P < 0.05 for both). Immunostaining demonstrated that iNOS localized to endothelium, glial fibrillary acidic protein (GFAP) positive (astrocytes) and GFAP negative cells within the brain. Plasma cytokine levels (tumour necrosis factor alpha, interleukin (IL)-1beta and IL-6) increased transiently, to the same levels, in both control and hemodiluted rats.
CONCLUSIONS: Cerebral cortical iNOS and nNOS protein levels were both increased in anemic rats. The nNOS response was predominant. This suggests that NOS-derived NO may be an important signalling pathway which is activated in the brain during anemia. These cellular responses could maintain cerebral homeostasis, or contribute to neuronal injury, during acute hemodilutional anemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412649     DOI: 10.1007/s12630-009-9104-z

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  6 in total

1.  Inhibition of neuronal nitric oxide synthase activity does not alter vasopressin secretion in septic rats.

Authors:  Camila Henriques Coelho; Thalita Freitas Martins; Gabriela Ravanelli Oliveira-Pelegrin; Maria José Alves da Rocha
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

Review 2.  Hypoxemia, oxygen content, and the regulation of cerebral blood flow.

Authors:  Ryan L Hoiland; Anthony R Bain; Mathew G Rieger; Damian M Bailey; Philip N Ainslie
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-12-16       Impact factor: 3.619

Review 3.  Transfusion practices in traumatic brain injury.

Authors:  James M East; Julien Viau-Lapointe; Victoria A McCredie
Journal:  Curr Opin Anaesthesiol       Date:  2018-04       Impact factor: 2.706

4.  Astrocyte HIF-2α supports learning in a passive avoidance paradigm under hypoxic stress.

Authors:  Cindy V Leiton; Elyssa Chen; Alissa Cutrone; Kristy Conn; Kennelia Mellanson; Dania M Malik; Michael Klingener; Ryan Lamm; Michael Cutrone; John Petrie; Joher Sheikh; Adriana DiBua; Betsy Cohen; Thomas F Floyd
Journal:  Hypoxia (Auckl)       Date:  2018-11-08

5.  Clinico-radiological Profile of Posterior Reversible Encephalopathy Syndrome and Its Associated Risk Factors in PICU: A Single-center Experience from a Tertiary Care Hospital in Bhubaneswar, Odisha.

Authors:  Chinmay K Behera; Mukesh K Jain; Reshmi Mishra; Pratap K Jena; Santosh K Dash; Ranjan K Sahoo
Journal:  Indian J Crit Care Med       Date:  2020-12

Review 6.  Anemia management after acute brain injury.

Authors:  Christophe Lelubre; Pierre Bouzat; Ilaria Alice Crippa; Fabio Silvio Taccone
Journal:  Crit Care       Date:  2016-06-17       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.